Boronophenylalanine‐Containing Polydopamine Nanoparticles for Enhanced Combined Boron Neutron Capture Therapy and Photothermal Therapy for Melanoma Treatment
Authors:
- 30 April 2024
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (38)
Abstract
Melanoma, the most aggressive skin cancer type, is challenging to treat due to its high metastatic potential and low response to conventional therapies. Innovative approaches, including combination therapies, are crucial for enhancing treatment efficacy while minimizing side effects. It is developed boronophenylalanine‐containing polydopaine (B‐PDA) nanoparticles by encapsulating boronophenylalanine in polydopamine through nitrogen‐boronate coordination, targeting both boron neutron capture therapy (BNCT) and photothermal therapy (PTT). With stability and biocompatibility under physiological conditions, these nanoparticles utilize the phenylalanine residues in BPA to target the overexpressed neutral amino acid transporter 1 (LAT1) in melanoma cells, resulting in enhanced cell‐specific targeting. B‐PDA nanoparticles demonstrated significant photothermal effects under external stimulation, inducing localized heating and triggering heterogeneous tumor cell death, thereby enhancing sensitivity to BNCT. Combining BNCT and PTT, the B‐PDA nanoparticles offer a promising strategy for melanoma treatment.Keywords
Funding Information
- Sichuan Provincial Postdoctoral Science Foundation (2023SCU12056)
- West China Hospital, Sichuan University (ZYGD18002)
- Fundamental Research Funds for Central Universities of the Central South University (20826041F4138)
- Sichuan Provincial Science and Technology Support Program (2023NSFSC0612)
- Science and Technology Support Program of Jiangsu Province (2022YFS0333)
- National Natural Science Foundation of China (U21A20417)
This publication has 33 references indexed in Scilit:
- Nanodelivery systems for cutaneous melanoma treatmentEuropean Journal of Pharmaceutics and Biopharmaceutics, 2023
- CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanomaNano Research, 2021
- Non-isotope enriched phenylboronic acid-decorated dual-functional nano-assembles for an actively targeting BNCT drugBiomaterials, 2021
- Metallacarboranes on the Road to Anticancer Therapies: Cellular Uptake, DNA Interaction, and Biological Evaluation of Cobaltabisdicarbollide [COSAN]−Chemistry – A European Journal, 2018
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeCell, 2018
- Novel Intrapolymerization Doped Manganese‐Eumelanin Coordination Nanocomposites with Ultrahigh Relaxivity and Their Application in Tumor TheranosticsAdvanced Science, 2018
- Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapyBiotechnology Advances, 2016
- Pilot clinical study of boron neutron capture therapy for recurrent hepatic cancer involving the intra-arterial injection of a 10BSH-containing WOW emulsionApplied Radiation and Isotopes, 2014
- BNCT for locally recurrent head and neck cancer: Preliminary clinical experience from a phase I/II trial at Tsing Hua Open-Pool ReactorApplied Radiation and Isotopes, 2011
- Uptake of two 10B‐compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001)International Journal of Cancer, 2007